Advertisement
Singapore markets close in 20 minutes
  • Straits Times Index

    3,328.74
    -1.35 (-0.04%)
     
  • Nikkei

    38,556.87
    -298.50 (-0.77%)
     
  • Hang Seng

    18,477.01
    -344.15 (-1.83%)
     
  • FTSE 100

    8,237.25
    -16.93 (-0.21%)
     
  • Bitcoin USD

    67,775.49
    -168.70 (-0.25%)
     
  • CMC Crypto 200

    1,458.87
    -25.83 (-1.74%)
     
  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     
  • Dow

    38,852.86
    -216.74 (-0.55%)
     
  • Nasdaq

    17,019.88
    +99.08 (+0.59%)
     
  • Gold

    2,347.40
    -9.10 (-0.39%)
     
  • Crude Oil

    80.41
    +0.58 (+0.73%)
     
  • 10-Yr Bond

    4.5420
    +0.0750 (+1.68%)
     
  • FTSE Bursa Malaysia

    1,608.94
    -6.88 (-0.43%)
     
  • Jakarta Composite Index

    7,155.46
    -98.16 (-1.35%)
     
  • PSE Index

    6,411.41
    -89.93 (-1.38%)
     

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Mesa Laboratories, Inc.
Mesa Laboratories, Inc.

LAKEWOOD, Colo., April 01, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024.

About Mesa Laboratories, Inc.

Mesa is a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

ADVERTISEMENT

For more information about the Company, please visit our website at www.mesalabs.com.

CONTACT: CONTACT: Gary Owens, President and CEO, or John Sakys, CFO, both of Mesa Laboratories, Inc., +1-303-987-8000